Company description

FAREVA is a global CMO with 40 production sites, with a Pharma Sector that specializes in the development, commercialization, and launch of API and Drug Product. FAREVA’s API group has industry leading expertise in the areas of development & optimization of complex synthesis, HP-API, aseptic processing, cryogenic, hydrogenation, steroids, spray drying, PSD and polymorph control with volumes ranging from 10 kg to 250 MT. Our Drug Product and Formulations group specializes in sterile solutions / suspensions, lyophilization, tablets, capsules, sprays / aerosols, liquids / gels, powder filling, Ophthalmics (BFS, bottles, tubes), suppositories, and high potent oral formulations. All sites are FDA / EU approved and our packaging is fully serialized to meet the newest regulations. Fareva is the first and only company in the world to receive SafeBridge Certification to handle both high potent drug substance and drug product at the same facility.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Aerosols |Analytical Chemistry |Analytical Development More

Recently at

16 may 2017

CPhI North America 2017

16-18 May, 2017 Philadelphia, USA We were at stand 949 See our Exhibitor Profile   See full Exhibitor List

Contact information




View all contact information